Stock Screener App
Gratuito
-
Play Store
App Store
Installare
Installare
Dark
IT
Sign in
Lista di controllo
Liste migliori
Mercati
Nuovo
Criptovalute
Industrie
Elite
Simulatore di mercato
Dow:
Nasdaq:
S&P 500:
Pagina iniziale
›
NASDAQ: INSM
›
Notizia
INSM
$112.58
0.89%
0.99
Dopo l'orario di chiusura: 112.01
-0.57 -0.51%
Insmed Inc (INSM)
Indicatore
1D
1W
1M
6M
YTD
1Y
5Y
MAX
Line
Candle
SMA
RSI
BB
Date:
2026-10-30 16:00
O:
113.60
H:
116.37
L:
111.97
C:
112.58
Vol:
5.184M
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Finanziari
Forum
Previsione
Frazionamento azionario
Insmed Inc Borsa (INSM) Ultime notizie
Oct 30, 2026
INSM Q3 Earnings Miss, Stock Soars on Sales Beat & Raised Guidance
- Zacks Investment Research
Oct 30, 2026
Oct 30, 2026
Goldman Sachs reiterates Insmed stock rating on Brinsupri beat
- Investing.com
Oct 30, 2026
Oct 30, 2026
Insmed shares fall as CFO Bonstein to exit Oct 30; 2026 guidance held
- scanx.trade
Oct 30, 2026
Oct 30, 2026
Key facts: INSM $524.4M Q3 Rev; FDA Priority Review; $1.1B Cash
- TradingView
Oct 30, 2026
Oct 29, 2026
Stifel cuts Insmed stock price target to $195 on OpEx outlook By Investing.com
- Investing.com South Africa
Oct 29, 2026
Oct 29, 2026
Insmed Incorporated reports results for the quarter ended September 30 - Earnings Summary
- TradingView
Oct 29, 2026
Oct 29, 2026
Insmed Inc (INSM) Q3 2026 Earnings Call Highlights: Brinsupri Hits Blockbuster Status as ...
- Yahoo Finance
Oct 29, 2026
Oct 29, 2026
What Insmed (INSM) Said on Its Q3 Earnings Call
- Yahoo Finance
Oct 29, 2026
Oct 29, 2026
INSM Stock Jumps As BRINSUPRI Rollout Expands Globally
- StocksToTrade
Oct 29, 2026
Oct 29, 2026
Insmed surges on Q3 revenue beats, revenue guidance range raise
- TradingView
Oct 29, 2026
Oct 29, 2026
Non-Cystic Fibrosis Bronchiectasis Pipeline Landscape 2026: Late-Stage Candidates, MOA Trends, and ROA | Insmed, AstraZeneca, Zambon, CSL Behring, Chiesi Farmaceutici
- StreetInsider
Oct 29, 2026
Oct 29, 2026
Insmed Q3 Net Loss Narrows; Revenue Rises
- www.marketscreener.com
Oct 29, 2026
Oct 29, 2026
Insmed jumps after strong Q3 revenue growth and higher 2026 product guidance
- Quiver Quantitative
Oct 29, 2026
Oct 29, 2026
Insmed Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
- www.marketscreener.com
Oct 29, 2026
Oct 29, 2026
Huntington Ingalls, Crocs, Carvana, Insmed And Other Big Stocks Moving Higher On Thursday
- Benzinga
Oct 29, 2026
Oct 29, 2026
Earnings call transcript: Insmed Q3 2026 revenue beats as BRINSUPRI surges
- Investing.com Canada
Oct 29, 2026
Oct 29, 2026
Insmed (INSM) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
- Yahoo Finance
Oct 29, 2026
Oct 29, 2026
Earnings Flash (INSM) Insmed Posts Q3 Loss $0.46 a Share, vs. FactSet Est of $0.38 Loss
- marketscreener.com
Oct 29, 2026
Oct 29, 2026
Insmed Q3 2026 Earnings Call Is Live
- TradingView
Oct 29, 2026
Oct 29, 2026
Why is Insmed stock surging today? By Investing.com
- Investing.com Canada
Oct 29, 2026
Oct 29, 2026
Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates
- Yahoo Finance
Oct 29, 2026
Oct 29, 2026
Insmed 3Q 2026: Revenue $524.4M, Net loss $100.3M, EPS $(0.46) — 10-Q Summary
- TradingView
Oct 29, 2026
Oct 29, 2026
Insmed Q3 Revenue Reaches $524.4 Million as BRINSUPRI Sales Rise
- Quiver Quantitative
Oct 29, 2026
Oct 29, 2026
Insmed: Q3 Earnings Snapshot
- Yahoo Finance
Oct 29, 2026
Oct 29, 2026
Insmed Reports Third-Quarter 2026 Financial Results and Provides Business Update
- www.marketscreener.com
Oct 29, 2026
Oct 29, 2026
Insmed Reports Q3 Revenue of $524.4 Million and Raises 2026 Guidance
- TradingView
Oct 29, 2026
Oct 29, 2026
Insmed Incorporated (INSM) Q3 Revenue $524.4M; Raises 2026 Guidance
- TradingView
Oct 29, 2026
Oct 29, 2026
Insmed Reports Third-Quarter 2026 Financial Results and Provides Business Update
- TradingView
Oct 29, 2026
Oct 28, 2026
Insmed set to report earnings as Japan launch tests growth story By Investing.com
- Investing.com South Africa
Oct 28, 2026
Oct 28, 2026
Insmed set to report earnings as Japan launch tests growth story
- Investing.com
Oct 28, 2026
Oct 27, 2026
Will Kura Oncology (KURA) Report Negative Q3 Earnings? What You Should Know
- Zacks Investment Research
Oct 27, 2026
Oct 27, 2026
H.C. Wainwright reiterates Insmed stock rating on pipeline progress By Investing.com
- Investing.com Canada
Oct 27, 2026
Oct 23, 2026
Insmed Incorporated Estimates – BMV:INSM
- TradingView
Oct 23, 2026
Oct 23, 2026
Insmed Incorporated (INSM) stock price, news, quote and history
- Yahoo Finance Australia
Oct 23, 2026
Oct 23, 2026
Al Sandrock to step down as Voyager CEO; Insmed adds Paul Hudson to board
- Endpoints News
Oct 23, 2026
Oct 22, 2026
$100 Invested In Insmed 15 Years Ago Would Be Worth This Much Today
- Benzinga
Oct 22, 2026
Oct 22, 2026
The Escalator: CSL, Insmed, Amgen and more
- Medical Marketing and Media
Oct 22, 2026
Oct 22, 2026
Insmed names former Sanofi and Novartis CEO Hudson and biopharma exec Koppikar to board
- ROI-NJ
Oct 22, 2026
Oct 22, 2026
Insmed (INSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- Zacks Investment Research
Oct 22, 2026
Oct 22, 2026
Insmed (INSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- Yahoo Finance
Oct 22, 2026
Oct 21, 2026
Insmed Needs Brinsupri To Prove Its Organic Ramp After A 25% Post-Raise Slide
- Finviz
Oct 21, 2026
Oct 21, 2026
Form 4 Insmed Inc: Paul Hudson (Director) For: 19 October By Investing.com
- Investing.com South Africa
Oct 21, 2026
Oct 20, 2026
Form 4 Insmed Inc: Paul Hudson (Director) For: 19 October By Investing.com
- Investing.com Canada
Oct 20, 2026
Oct 20, 2026
Utpal Koppikar Appointed to Insmed Board, Reports No Ownership of Company Securities
- Kalkine Media
Oct 20, 2026
Oct 20, 2026
Insmed Appoints Two New Directors to Its Board
- Insmed Incorporated Investor Relations
Oct 20, 2026
Oct 20, 2026
Form 8K Insmed Inc For: 20 October By Investing.com
- Investing.com Nigeria
Oct 20, 2026
Oct 20, 2026
Insmed adds two directors with pharma leadership experience
- Investing.com
Oct 20, 2026
Oct 20, 2026
Insmed appoints Paul Hudson and Utpal Koppikar to its Board
- TradingView
Oct 20, 2026
Oct 20, 2026
Insmed adds two independent directors with biopharma backgrounds
- StreetInsider
Oct 20, 2026
Oct 20, 2026
Insmed Appoints Two New Directors to Its Board
- Yahoo Finance
Oct 20, 2026
Simile a INSM
INCY
$120.39
3.07%
ROIV
$36.91
1.63%
BNTX
$88.17
1.08%
ALNY
$165.00
5.17%
RPRX
$67.18
1.90%
EXEL
$69.39
4.82%
Apri in Yahoo
|
Apri in Google
|
Apri in Finviz
|
Apri in MarketWatch
|
Apri in EDGAR
|
Apri in Reuters